Beam Therapeutics Inc.
Net Cash Flow Breakdown
Total Cash from Operations: $210.1M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $49.0M | 23.3% |
| Other Investing | $85.2M | 40.5% |
| Working Capital | $75.9M | 36.2% |
| Net Cash Flow | $0 | 0.0% |
Net Cash Flow Breakdown
Total Cash from Operations: $210.1M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $49.0M | 23.3% |
| Other Investing | $85.2M | 40.5% |
| Working Capital | $75.9M | 36.2% |
| Net Cash Flow | $0 | 0.0% |